StockData
Passage BIO, Inc. logo

Passage BIO, Inc. (PASG) stock

PASGNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/30
$4.22+0.09 (+2.18%)

Close on Nov 17, 2026Market cap $13.58MP/E –Yield –

Passage BIO price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Passage BIO's price to book ratio was 2.9× on Nov 11, 2026, against 0.9× a year earlier. Over the last 5 years it ranged from 0.2× to 3.2×, with a median of 0.5×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20262.9×+1.7
2025Dec 31, 20251.2×+0.7
2024Dec 31, 20240.5×+0.0
2023Dec 29, 20230.4×+0.1
2022Dec 30, 20220.3×−0.6
2021Dec 31, 20211.0×−2.6
2020Dec 31, 20203.5×–

More Passage BIO figures

See a number that looks wrong?